# EDGAR Filing Document

**Accession Number:** 0001888886
**File Stem:** 0001104659-23-008578
**Filing Date:** 2023-1
**Character Count:** 3178
**Document Hash:** cc3a7a65f2f43943e80f267c3863cb28
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-008578.hdr.sgml**: 20230306

**ACCESSION NUMBER**: 0001104659-23-008578

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Structure Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0001888886
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 981480821
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 611 GATEWAY BLVD SUITE 223
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** (628) 229-9277

**MAIL ADDRESS:**
- **STREET 1:** 611 GATEWAY BLVD SUITE 223
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ShouTi Inc.
- **DATE OF NAME CHANGE:** 20211019

STRUCTURE THERAPEUTICS INC.

611 Gateway Blvd., Suite 223

South San Francisco, CA 94080

January 31, 2023

***VIA EDGAR***

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Attn: | Vanessa Robertson |
|  | Terence O'Brien |
|  | Jimmy McNamara |
|  | Joe McCann |

---

---

| | |
|:---|:---|
| **Re:** | **Structure Therapeutics Inc.** |
|  | **Registration Statement on Form S-1, as amended (File No. 333-269200)** |
|  | **Request for Acceleration of Effective Date** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Structure Therapeutics Inc. (the "<u>Company</u>") hereby requests that the Securities and Exchange Commission (the "<u>Commission</u>") accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the "<u>Registration Statement</u>") and declare the Registration Statement effective as of 4:00 p.m. Eastern time, on February 2, 2023, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone to the staff of the Commission. The Company hereby authorizes each of Patrick Loofbourrow and Charles S. Kim of Cooley LLP, counsel to the Company, to make such a request on its behalf. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from Cooley LLP confirming this request.

Once the Registration Statement has been declared effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (619) 840-4824, or in his absence, Charles S. Kim of Cooley LLP at (858) 550-6049.

Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company's request for acceleration of the effectiveness of the Registration Statement.

[Signature page follows]

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Structure Therapeutics Inc. | Structure Therapeutics Inc. |
| /s/ Raymond Stevens | /s/ Raymond Stevens |
| By: | Raymond Stevens |
| Title: | Chief Executive Officer |

---

[Signature Page to Acceleration Request]